Cellular and pathological functions of tau

C Parra Bravo, SA Naguib, L Gan - Nature Reviews Molecular Cell …, 2024 - nature.com
Tau protein is involved in various cellular processes, including having a canonical role in
binding and stabilization of microtubules in neurons. Tauopathies are neurodegenerative …

Multifaceted roles of APOE in Alzheimer disease

RJ Jackson, BT Hyman, A Serrano-Pozo - Nature Reviews Neurology, 2024 - nature.com
For the past three decades, apolipoprotein E (APOE) has been known as the single greatest
genetic modulator of sporadic Alzheimer disease (AD) risk, influencing both the average age …

Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model

J Hou, Y Chen, Z Cai, GS Heo, CM Yuede… - Science translational …, 2024 - science.org
Microglia help limit the progression of Alzheimer's disease (AD) by constraining amyloid-β
(Aβ) pathology, effected through a balance of activating and inhibitory intracellular signals …

Innate immune activation in neurodegenerative diseases

S Castro-Gomez, MT Heneka - Immunity, 2024 - cell.com
Activation of the innate immune system following pattern recognition receptor binding has
emerged as one of the major pathogenic mechanisms in neurodegenerative disease …

Updates in Alzheimer's disease: from basic research to diagnosis and therapies

E Liu, Y Zhang, JZ Wang - Translational Neurodegeneration, 2024 - Springer
Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized
pathologically by extracellular deposition of β-amyloid (Aβ) into senile plaques and …

Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer's disease profile and possible mechanisms of disease protection

MC Almeida, SJ Eger, C He, M Audouard, A Nikitina… - Neuron, 2024 - cell.com
Highly penetrant autosomal dominant Alzheimer's disease (ADAD) comprises a distinct
disease entity as compared to the far more prevalent form of AD in which common variants …

[HTML][HTML] New insights into innate immunity in Alzheimer's disease: From APOE protective variants to therapies

Y Chen, DM Holtzman - Trends in Immunology, 2024 - cell.com
Recent discoveries of rare variants of human APOE may shed light on novel therapeutic
strategies for Alzheimer's disease (AD). Here, we highlight the newly identified protective …

APOE from astrocytes restores Alzheimer's Aβ-pathology and DAM-like responses in APOE deficient microglia

P Preman, D Moechars, E Fertan, L Wolfs… - EMBO Molecular …, 2024 - embopress.org
The major genetic risk factor for Alzheimer's disease (AD), APOE4, accelerates beta-amyloid
(Aβ) plaque formation, but whether this is caused by APOE expressed in microglia or …

Report of the APOE4 National Institute on Aging/Alzheimer disease sequencing project consortium working group: reducing APOE4 in carriers is a therapeutic goal for …

JM Vance, LA Farrer, Y Huang, C Cruchaga… - Annals of …, 2024 - Wiley Online Library
Alzheimer's disease (AD) is the most common neurodegenerative disorder and one of the
leading causes of disability worldwide. The apolipoprotein E4 gene (APOE4) is the strongest …

An enzymatically activated AND-gate DNA logic circuit for tumor cells recognition via multi-microRNAs detection

H Yan, G Cao, J Wang, X Zhu, S Dong, Y Huang… - Biosensors and …, 2024 - Elsevier
The DNA-based logic circuit, constructed to mimic biochemical reaction networks, is highly
significant in detecting biomarkers at the molecular level. The differences in the expression …